Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Johnson and Johnson
McKesson
Baxter
McKinsey

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

CHORIONIC GONADOTROPIN Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Chorionic Gonadotropin, and what generic alternatives are available?

Chorionic Gonadotropin is a drug marketed by Bel Mar, Ferring, and Fresenius Kabi Usa. and is included in three NDAs.

The generic ingredient in CHORIONIC GONADOTROPIN is gonadotropin, chorionic. Three suppliers are listed for this compound. Additional details are available on the gonadotropin, chorionic profile page.

Summary for CHORIONIC GONADOTROPIN
Drug patent expirations by year for CHORIONIC GONADOTROPIN
Recent Clinical Trials for CHORIONIC GONADOTROPIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Moustafa Mohammed AboueleaEarly Phase 1
Assistance Publique - Hôpitaux de ParisPhase 2
Sohag UniversityPhase 4

See all CHORIONIC GONADOTROPIN clinical trials

US Patents and Regulatory Information for CHORIONIC GONADOTROPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bel Mar CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017054-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ferring CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017016-010 Feb 15, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Ferring CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017016-011 Feb 16, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017067-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ferring CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017016-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bel Mar CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017054-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Johnson and Johnson
Harvard Business School
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.